02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

348A AASLD ABSTRACTS HEPATOLOGY, October, 2015<br />

(64.9-83.4), PPV 34.3% (19.1-52.2) and VPN 97.2% (90.2-<br />

99.7). In this study, the prevalence of SIRS was 13.2%. In<br />

5 samples, neutrophil count was above 250/mm 3 (385 to<br />

13020/ mm 3 ) but the strip was considered as negative. When<br />

setting “trace” as the first positive result, Se and NPV were both<br />

of 100% for outpatients. Conclusions: This study shows, for the<br />

first time, in a large sample size of cirrhotic patients that the<br />

Periscreen TM strip is a robust screening tool for the detection of<br />

SBP. More importantly, this new leukocyte esterase strip has<br />

an excellent accuracy to exclude SBP in the outpatient setting.<br />

(1) Nousbaum JB, et al. Hepatology 2007;45:1275-1281. (2)<br />

Mendler MH, J Hepatol 2010;53:477-483.<br />

Disclosures:<br />

Alexandra Heurgué-Berlot - Consulting: Abbvie; Speaking and Teaching: Gilead<br />

Christophe Bureau - Grant/Research Support: Gore; Speaking and Teaching:<br />

Gore<br />

Isabelle Ollivier-Hourmand - Speaking and Teaching: gilead, jansen, bayer<br />

Eric Nguyen-Khac - Speaking and Teaching: Gilead, Abbvie, Janssen, Roche,<br />

MSD, BMS<br />

Si Nafa Si Ahmed - Board Membership: La Roche Hoffmann; Grant/Research<br />

Support: Janssen; Speaking and Teaching: BMS, Gilead, Abbvie<br />

The following authors have nothing to disclose: Thierry Thevenot, Charline Briot,<br />

Vincent Macé, Hortensia Lison, Laure Elkrief, Caroline Jezequel, Ghassan Riachi,<br />

Alexandre Louvet, Hélène Labadie, Nicolas Carbonell, Karim Aziz, Denis Grasset,<br />

Rodolphe Anty, Mehdi Kaasis, Thomas Mouillot, Arnaud Pauwels, Florence<br />

Tanné, Jean Paul Cervoni, Jean françois D. Cadranel, Matthieu Schnee<br />

265<br />

Deleterious effect of beta-blockers in cirrhotic patients<br />

with refractory ascites: potential role of myocardial dysfunction<br />

Valerio Giannelli 1,2 , Olivier Roux 2 , Pierre-Emmanuel Rautou 2 ,<br />

Emmanuel Weiss 2 , Richard Moreau 2 , Didier Lebrec 2 , Francois<br />

Durand 2 , claire francoz 2 ; 1 gastroenterology, university of rome<br />

“sapienza”, Rome, Italy; 2 Service d’Hépatologie, Hôpital Beaujon,<br />

Assistance Publique-Hôpitaux de Paris, Clichy, France; INSERM<br />

U1149,CRI, Paris, France<br />

Introduction: Recent <strong>studies</strong> have suggested that non selective<br />

beta-blockers (NSBB) could be deleterious in cirrhotic patients<br />

with refractory ascites (RA) by increasing transplant-free mortality.<br />

It has been proposed that NSBB may increase the risk<br />

of paracentesis-induced circulatory dysfunction but the mechanisms<br />

involved are still unclear. The aim of this study was to<br />

explore the impact of NSBB on systemic and splanchnic hemodynamics<br />

in cirrhotic patients with RA evaluated for liver transplantation<br />

(LT). Patients and methods: 583 cirrhotic patients<br />

evaluated for a first LT in a single center between 1997 and<br />

2013 were studied. There were 74% males, mean age was<br />

52 years. The cause of cirrhosis was alcohol in 43%, HCV<br />

in 24% and HBV in 11%. 29% of patients had hepatocellular<br />

carcinoma. 196 patients (34%) had RA, and among them, 51<br />

% received NSBB. Physiological MELD score was comparable<br />

in RA and no—RA groups (17 vs 16, ns) as well as the proportion<br />

of patients receiving NSBB (51 vs 51 %, ns). In addition<br />

to standard preLT workup, all patients had measurement of<br />

both splanchnic and systemic hemodynamics by right heart<br />

catheterization with assessment of cardiac work (Left and Right<br />

Ventricular Stroke Work Index, LVSWI and RVSW). Results:<br />

Waiting list mortality was higher in RA compared to no-RA<br />

group, (62 vs 38 % at 1 year, p=0.001). RA patients had significantly<br />

lower mean arterial pressure (MAP) lower heart rate<br />

(HR) and higher hepatic venous pressure gradient (HVPG) than<br />

no-RA patients. Cardiac index (CI) as well as systemic vascular<br />

resistance (SVRI) were similarcomparable in both groups. By<br />

contrast, Left and Right Ventricular Stroke Work Index (LVSWI<br />

and RVSWI) were significantly lower in RA patients compared<br />

to no-RA. In both RA and no-RA patients, NSBB resulted in a<br />

significant decrease in HR, MAP, and CI. In the no-RA group,<br />

NSBB did not affect LVSWI (57+15 vs 60+21 g.m/m 2 , ns). By<br />

contrast, in the RA group, NSBB were associated with a significant<br />

decrease in LVSWI (48+15 vs 56+15, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!